Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-161 in moderate to severe dry eye disease
NCT04084483Phase 2Completed
- Start
- Aug 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of K-161 in dry eye disease (DED). Started Aug 2019; status: completed.
02
Drugs
K-161
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04084483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04084483.